Launch of Clinical Research Development IrelandFarmleigh House, Dublin | 2 October 2017

28 Upper Mount St Dublin 2, D02 CX28T: +353 1 658 2120 E: info@crdi.ie W: www.crdi.ie

Enabling Clinical and Translational Research

PROGRAMME

10:00 Registration and refreshments11:00 Dr Pat O’Mahony, Chief Executive of Clinical Research Development Ireland Welcome and introduction of new logo11:15 Mr Thomas Lynch, Chairman of Clinical Research Development Ireland Reflections as Chairman 11:25 Professor Dermot Kelleher, Dean of the Faculty of Medicine, University of British Columbia Molecular medicine is good medicine - the evolution of MMI11:45 Professor Martin O’Donnell, CRDI Board Director & Professor of Translational Medicine, NUI Galway Clinical Research Development Ireland – opportunities and challenges12:05 Dr Pat O’Mahony Clinical Research Development Ireland Strategy, 2017 - 202112:20 Mr Simon Harris TD, Minister for Health Address and unveiling of new plaque12:35 Questions & Answers with panel of speakers12:55 Mr Thomas Lynch Closing remarks 13:00 Light Lunch

Tweet us @CRDIreland

2002Dublin Molecular Medicine Centre (DMMC) established by TCD and UCD

2005RCSI joinsDMMC

2005Irish Clinical Research Infrastructure Network (ICRIN) formed by DMMC partners, NUI Galway & UCC

2006European Clinical Research Infrastructure Network (ECRIN) membership awarded

2008Molecular Medicine Ireland (MMI) established by NUI Galway, RCSI, TCD, UCC and UCD

2008Clinician Scientist Fellowship Programme launched

2008Dublin Centre for Clinical Research established

2011Clinical & Translational Research Scholars Programme launched

2013Irish Programme for Stratified Prostate Cancer Therapy (iPROSPECT) funding awarded

2017Clinical Research Development Ireland (CRDI) launched

2 October 2017 marks the rebrand of Molecular Medicine Ireland as Clinical Research Development Ireland (CRDI). CRDI is a not-for-profit research partnership established in 2008 as Molecular Medicine Ireland by the NUI Galway, Royal College of Surgeons in Ireland, Trinity College Dublin, University College Cork and University College Dublin, their medical schools, associated academic hospitals and clinical research facilities, with the objective of accelerating the translation of biomedical research into improved diagnostics, therapies and devices for patients.

CRDI builds on the achievements of Molecular Medicine Ireland which was established in 2008 by the five aforementioned universities, together with its predecessor the Dublin Molecular Medicine Centre (DMMC), a partnership initiated by UCD and Trinity College Dublin in 2002, with the inclusion of Royal College of Surgeons in Ireland in 2005.

CRDI is funded by the five universities along with programme funding from a number of sources including the Health Research Board, Enterprise Ireland, Wellcome Trust, Science Foundation Ireland, Irish Cancer Society and the Health Service Executive.

INTRODUCING CLINICAL RESEARCH DEVELOPMENT IRELAND

2014Irish Prostate Cancer Outcomes Research (IPCOR) funding awarded

2015HRB Clinical Research Coordination Ireland established

2015Centre for Research in Medical Devices (CÚRAM) funding awarded

2016Irish Clinical Academic Training (ICAT) Programme funding awarded